Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 384 for “"Neutralizing antibody"”.
-
Characterizing the neutralizing antibody responses of HIV-1 superinfected individuals
Eliciting a neutralizing antibody (Nab) response that is protective against diverse HIV-1 variants presents a major challenge to vaccine development. The identification of broad, cross-reactive Nabs from HIV-infected individuals has revealed epitopes on the HIV-1 Envelope that could be exploited by …
-
Defining neutralizing antibody specificities that target diverse HIV-1 transmitted strains
… in animal models have shown that pre-existing neutralizing antibodies (NAbs), which target the human immunodeficiency virus type 1 (HIV-1) envelope (Env) to prevent entry into host cells, can block infection. A limitation of these models is that typically only one challenge virus is used. Given …
-
Examining neutralizing antibody activity as an immune correlate of HIV-1 superinfection
… to induce. Objective: To examine the role of neutralizing antibody (NAb) activity in protecting against HIV-1 superinfection. Design/Methods: In the largest assessment of pre-superinfection NAb activity to date, we quantified NAb breadth and potency, based on neutralization of 4 diverse Env …
-
Deciphering HIV-1 Envelope Glycoprotein Traits That Steer Broadly Neutralizing Antibody Evolution
… a protective vaccine that elicits broadly neutralizing antibodies (bnAbs) capable of circumventing the neutralization evasion mechanisms and extreme genetic heterogeneity of the HIV-1 Envelope glycoprotein (Env). Studies of bnAb development in people with HIV (PWH) have provided evidence …
-
HIV-1 Envelope Plasticity and Its Interplay with Broad Neutralizing Antibody Activity
… antiviral vaccines work by eliciting protective antibody responses. These antibodies, to be an effective force against HIV-1 infection, must impede the entry process by binding to the viral envelope (Env) glycoprotein. This glycoprotein plays a critical role in facilitating the attachment of the …
-
Broad and Potent Neutralizing Antibody Responses Elicited in Natural HIV-2 Infection
… potency, breadth and epitope specificities of neutralizing antibody (Nab) responses elicited in natural HIV-2 infection. Analysis of plasma specimens from 64 HIV-2 chronically-infected subjects in a single round infectivity assay (JC53bl-13/TZM-bl) revealed median reciprocal IC50 Nab titers of …
-
A study of the thermostable neutralizing antibody resulting from ragweed pollen injections
Thesis (M.D.)—Boston University
-
SARS-CoV-2 spike trimer complexed with a durable neutralizing antibody 6C6 fab
… we were able to show that a novel SARS-CoV-2 antibody, 6C6, binds to the spike protein and can be isolated through size exclusion techniques. The results provide evidence that 6C6 binds to the receptor binding motif (RBM) with high affinity and can be complexed with the spike protein …
-
Development and Characteristics of the Earliest Cross-Neutralizing Antibody Response to HIV-1
A neutralizing antibody response of sufficient potency, magnitude and duration is considered an important part of a successful HIV vaccine. A better understanding of the factors associated with the development of broadly neutralizing antibody responses (effective against a wide range of clinical …
-
Investigating the role of ANXA2 neutralizing antibody as a potential therapy for pathologic retinal angiogenesis
… the proangiogenic growth factor, ANXA2 and its neutralizing antibody in the disease progression of ROP using the mouse model of oxygen-induced retinopathy (OIR). ANXA2 neutralizing antibody was intravitreally injected into the eyes of wildtype C57BL/6J mouse pups to target the expression of …
-
Functional and Structural Studies of Respiratory Syncytial Virus Fusion (RSV F) Protein and Neutralizing Antibody
… of efficient RSV vaccine or therapeutic antibody has been a priority globally. RSV fusion (F) glycoprotein on the surface of the particle plays a central role in infection, mediating viral entry into host. It is an almost exclusive target for vaccine design and therapeutic antibody …
-
Droplet Microfluidic Screening Systems: From High Throughput Neutralizing Antibody Discovery to Advanced DNA Transfer Devices
… & DNA ENTRAP, that aim to disrupt the field of neutralizing antibody discovery and genetic engineering, respectively. Furthermore, this works presents novel solutions to several commonplace droplet microfluidic bottlenecks that help advance the field and achieve this idea of self-sufficient, …
-
Kinetics of Immune Cells and Neutralizing Antibody Titres Against Viral Pathogens of Bovine Respiratory Disease
Bovine Respiratory Disease (BRD) arises from complex interactions between viral and bacterial pathogens, environmental stressors, and host factors. BRD significantly impact feedlots due to its high prevalence, economic impact, and animal welfare concerns. Therefore, implementing an effective …
-
Development and Evaluation of an Isospora Suis Sporozoite Neutralizing Antibody Assay in Swine Testicular Cells
An in vitro Isospora suis sporozoite neutralizing antibody assay has been developed in swine testicular (ST) cells. This assay measures the titer of neutralizing antibodies present in sera, milk and monoclonal antibody culture fluids by determining both the amount of intracellular sporozoites by …
-
Characterization of the neutralizing antibody response over time induced by monovalent and tetravalent dengue vaccine formulations
… the standard method to evaluate the amount of neutralizing antibody elicited by a vaccine (PRNT50) does not measure the effects of non-neutralizing antibody activity, which is problematic in the context of dengue because the presence of non-neutralizing cross-reactive antibodies can cause …
-
FUNCTIONAL AND QUANTITATIVE THRESHOLDS OF AUTOLOGOUS NEUTRALIZING ANTIBODY POTENCY DEFINE THE REBOUND- COMPETENT HIV-1 RESERVOIR
… rebound sequences. Resistance to autologous neutralizing antibodies was critical for rebound. Using a pharmacodynamic parameter, the inhibitory potential (IP), we defined quantitative limits governing HIV-1 rebound-competency. Reservoir variants exhibited a wide range of IP values (0.4-8.2 …
Page 1 of 20